Toronto, Canada (PRWEB) June 12, 2012
Saringer Life Science Technologies Inc., a Canadian medical device manufacturer is causing major waves in the field of PTS with its unique sequential compression pump; the Venowave VW5. The Venowave VW5 is a unique, mobile venous-return assist device that is designed for even the most serious vascular conditions including Post Thrombotic Syndrome (PTS), Post Phlebitic Syndrome and Chronic Venous Insufficiency (CVI).
The Venowave VW5 uses a patented wave form motion to increase blood circulation in patients who suffer from various circulatory diseases including deep vein thrombosis (DVT) which can lead to the debilitating: post thrombotic syndrome, also known as PTS.
Post-Thrombotic Syndrome has always been a simultaneously easy and difficult clinical entity for practicing physicians. The easy part, physicians claim, is clinical presentation and diagnosis. When a patient complains of pain and swelling in the leg, has a history of deep vein thrombosis (DVT) of that same leg, a diagnosis of post-thrombotic venous insufficiency can be made on the spot and confirmed by a Doppler ultrasound. The difficult part, is how to manage the venous insufficiency. Traditionally, the gold standard in PTS treatment was custom fitted elastic graduated compression stockings. There are limitations associated with the use of elastic compression stockings including lack of compliance, comfort and overall effectiveness in reducing actual PTS symptoms. Other forms of PTS treatment are quite scarce leaving PTS sufferers largely underserved and vulnerable.
After a lack of advancement in the field for years, the Venowave was introduced and tested for treatment of severe PTS. The Venowave VW5, inspired by inventor and entrepreneur, John Saringer—working with Dr. Jack Hirsh, a professor of medicine at McMaster University, and associated teaching hospitals in Hamilton, Ontario—says the Venowave VW5 has a natural superiority over compression stockings. The device consists of a small peristaltic pump that is attached around the calf and mimics the body’s venous system relieving pressure & swelling. Although the application of mechanic compression devices to treat PTS is not entirely new, earlier devices were large and impractical. In contrast, The Venowave is smaller in size, lighter and completely cordless which allows for high patient compliance leading to more significant improvements for PTS patients.
The Venowave and its patented wave form motion technology is revolutionary in its field. The unit is lightweight (weighing less than a pound), discreet and allows the patient to remain completely mobile. By using The Venowave, a patient can resume their daily active lifestyles- in comfort. Saringer Life Science Technologies’ contributions to the field of PTS have come at an optimal time as PTS sufferers have been neglected for far too long.
Saringer Life Science Technologies Inc. is a privately-owned company that was founded by engineer/inventor, John Saringer. John works extensively with leading physicians/surgeons in the development of new and improved medical treatment devices in the fields of DVT prevention, vascular solutions, wound healing intervention and pain management. For more information, please visit http://www.venowave.com.